Literature DB >> 11897483

Pediatric granulomatous cerebral amebiasis: a delayed diagnosis.

Marcelo Galarza1, Vicente Cuccia, Fidel P Sosa, Jorge A Monges.   

Abstract

We present four cases of cerebral amebae infection treated at our neurosurgical department. Patient 1 was a 12-year-old male with skin lesions of 2 years' progression involving the midface. He received a corticosteroid course, and, after that, he presented a right body hemiparesis. Patient 2 was a 5-year-old male, with a past surgical history of fibula fracture and osteomyelitis of 1-year evolution, associated with lesions of the surrounding skin that presented with partial seizures. Patient 3 was a 3-year-old female who presented with a stroke-like episode and with partial seizures. Patient 4 was a 6-year-old male who had ulcerative lesions in the face of 1-year evolution. After a corticosteroid course, he presented with right-body hemiparesis. All patients were human immunodeficiency virus-negative and died 1 month or less after surgery because of progressive evolution of the disease. Histopathology revealed granulomatous amebic encephalitis. All patients revealed infection from Balamuthia mandrillaris (Leptomyxiidae). Treatment consisting of pentamidine, clarithromycin, fluconazole, and 5-fluorocytosine was ineffective. Although extremely uncommon, granulomatous amebic encephalitis should be considered in the differential diagnosis of cerebral lesions while nonspecific, associated granulomatous skin lesions support the diagnosis of amebiasis.

Entities:  

Mesh:

Year:  2002        PMID: 11897483     DOI: 10.1016/s0887-8994(01)00360-5

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  10 in total

1.  Balamuthia mandrillaris amoebic encephalitis: an emerging parasitic infection.

Authors:  Francisco G Bravo; Carlos Seas
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity.

Authors:  Ruqaiyyah Siddiqui; Abdul Matin; David Warhurst; Monique Stins; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

3.  Diagnosis of first case of Balamuthia amoebic encephalitis in Portugal by immunofluorescence and PCR.

Authors:  Marta Tavares; Jose M Correia da Costa; S Stirling Carpenter; L A Santos; Caldas Afonso; Alvaro Aguiar; Josue Pereira; Ana Isabel Cardoso; Frederick L Schuster; Shigeo Yagi; Rama Sriram; Govinda S Visvesvara
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 4.  Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease.

Authors:  Hongze Zhang; Xunjia Cheng
Journal:  Front Med       Date:  2021-11-26       Impact factor: 4.592

Review 5.  Increasing importance of Balamuthia mandrillaris.

Authors:  Abdul Matin; Ruqaiyyah Siddiqui; Samantha Jayasekera; Naveed Ahmed Khan
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient.

Authors:  Peter Lackner; Ronny Beer; Gregor Broessner; Raimund Helbok; Bettina Pfausler; Christian Brenneis; Herbert Auer; Julia Walochnik; Erich Schmutzhard
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

7.  Diagnosing Balamuthia mandrillaris encephalitis via next-generation sequencing in a 13-year-old girl.

Authors:  Xia Wu; Gangfeng Yan; Shuzhen Han; Yingzi Ye; Xunjia Cheng; Hairong Gong; Hui Yu
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

8.  A patient with granulomatous amoebic encephalitis caused by Balamuthia mandrillaris survived with two excisions and medication.

Authors:  Limei Peng; Quan Zhou; Yu Wu; Xiaoli Cao; Zili Lv; Minghua Su; Yachun Yu; Wen Huang
Journal:  BMC Infect Dis       Date:  2022-01-15       Impact factor: 3.090

9.  Amoebic encephalitis: case report and literature review of neuroimaging findings.

Authors:  Matthew William Lukies; Yoshiyuki Watanabe; Tetsuo Maeda; Shinsuke Kusakabe; Hideyuki Arita; Noriyuki Tomiyama
Journal:  BJR Case Rep       Date:  2016-07-28

10.  Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen Balamuthia mandrillaris.

Authors:  Matthew T Laurie; Corin V White; Hanna Retallack; Wesley Wu; Matthew S Moser; Judy A Sakanari; Kenny Ang; Christopher Wilson; Michelle R Arkin; Joseph L DeRisi
Journal:  mBio       Date:  2018-10-30       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.